ClinicalTrials.Veeva

Menu

Efficacy of the SurgiStim3 Electrical Stimulation Device in Persons Undergoing Anterior Cruciate Ligament Repair

V

VQ OrthoCare

Status and phase

Terminated
Phase 4

Conditions

Anterior Cruciate Ligament

Treatments

Device: SurgiStim3

Study type

Interventional

Funder types

Industry

Identifiers

NCT00717171
S060501-ACL

Details and patient eligibility

About

The purpose of this study is to determine whether a functional electrical stimulation device, the SurgiStim3, decreases pain, pain medications and/or edema in patients undergoing anterior cruciate ligament repair.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Agree to provide informed consent to be included within this ACL study
  • Demonstrate a continued willingness to be compliant with the parameters established under the study;
  • Have no history of drug or alcohol abuse in the last 2 years;
  • Be either a male or female adult between the ages of 18 and 64;
  • Be undergoing a surgical repair of the anterior cruciate ligament (ACL) using either a hamstring, patella tendon, Achilles tendon, or allograft procedure; and
  • Understand that there is no financial remuneration for participation in the study.

Exclusion criteria

  • Pregnant women
  • Insulin dependent diabetic patients
  • Patients with a demand type pacemaker
  • Patients who have a malignant tumor (other than basal cell epithelioma)
  • Patients with a known history of alcohol or drug abuse in the last 2 years
  • Patients who will not agree to provide informed consent to be included within this ACL study
  • Patients who demonstrate a continued unwillingness to be compliant with the parameters established under this study.
  • "Poor healers" as identified by the patient's medical history
  • Patients who have a history of sensitivity to surgical tape, electrode adhesives, etc.
  • Patients with a known history of RSD (reflex sympathetic dystrophy)
  • Patients with a history of chronic pain (on opiates or high dosage of NSAIDS for 3 months or greater)
  • Patients who have previously undergone an ACL reconstruction on the same knee
  • Patients with clinically varicose veins (clinically significant or symptomatic)
  • Patients whose history shows an abuse of diuretics or anti-inflammatory medications
  • Patients who will undergo multiple ligament surgery (i.e., ACL plus PCL, MCL, and/or LCL)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups, including a placebo group

1
Placebo Comparator group
Treatment:
Device: SurgiStim3
Device: SurgiStim3
2
Experimental group
Treatment:
Device: SurgiStim3
Device: SurgiStim3

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems